Commercial Engagement & Legal Framework

Effective Date: [Insert Date]

This Commercial Engagement & Legal Framework governs all business interactions with APINEXA relating to pharmaceutical sourcing, Active Pharmaceutical Ingredient (API) facilitation, supplier evaluation, and compliance advisory services. By accessing this website or entering into commercial discussions with APINEXA, you acknowledge and agree to the provisions set forth herein.

1. Nature of Services

APINEXA operates as a pharmaceutical sourcing and commercial facilitation company serving regulated international markets. Services may include quotation coordination, supplier identification, transaction structuring, and, upon formal engagement, independent supplier due diligence or on-site assessments.

APINEXA does not manufacture pharmaceutical products and does not act as a regulatory authority, certification body, or governmental institution.

2. Contractual Structure

Supply agreements for APIs or related materials are executed directly between the purchasing entity and the manufacturer unless APINEXA enters into a separate written principal agreement. APINEXA’s involvement is limited to commercial facilitation and structured coordination.

3. Regulatory and Compliance Responsibilities

The buyer is solely responsible for regulatory submissions, market authorization, import compliance, intellectual property due diligence, and lawful commercialization within the destination jurisdiction.

The manufacturer is solely responsible for GMP compliance, product conformity, documentation accuracy, export legality, and adherence to applicable pharmaceutical regulations.

APINEXA’s participation does not transfer statutory, regulatory, or legal obligations from the contracting parties.

4. Financial Terms

Commercial payment terms for product supply are determined exclusively between the contracting entities. Service fees payable to APINEXA are considered earned upon completion of the agreed scope and are non-refundable unless otherwise specified in a written agreement.

APINEXA shall not be liable for losses arising from fraudulent communications, unauthorized payment instructions, cybersecurity incidents beyond reasonable control, currency fluctuations, or banking system disruptions.

5. Independent Supplier Evaluation

Where formally engaged, APINEXA may conduct structured supplier assessments, documentation reviews, or site evaluations. Observations reflect professional findings at the time of review and do not constitute regulatory certification or warranty of ongoing compliance.

6. Limitation of Liability

APINEXA does not guarantee regulatory approvals, commercial profitability, delivery timelines, or uninterrupted supply performance.

To the fullest extent permitted by law, APINEXA excludes liability for indirect, incidental, consequential, or economic losses arising from transactions coordinated through its services. Where liability cannot be excluded, aggregate liability shall be limited to the service fees received for the specific engagement giving rise to the claim.

7. Dispute Communication

Disputes shall be resolved between the contracting buyer and manufacturer in accordance with their commercial agreement. APINEXA may assist in structured communication but does not act as arbitrator, guarantor, or insurer.

8. Intellectual Property Protection

All sourcing methodologies, proprietary databases, compliance frameworks, documentation formats, and website materials are the intellectual property of APINEXA. Unauthorized reproduction, scraping, redistribution, or commercial exploitation is prohibited.

9. Patent Disclaimer

APINEXA does not perform patent validity or freedom-to-operate analysis unless separately contracted. Buyers and manufacturers remain independently responsible for intellectual property evaluation within relevant jurisdictions.

10. Governing Law

This Framework shall be governed by the laws of India. Any dispute relating to APINEXA’s services shall be subject to the exclusive jurisdiction of the competent courts located in [Insert City], India.

Contact Information

APINEXA
[Registered Company Name]
[Registered Address]
Email: inquiries@apinexa.com
Website: www.apinexa.com

APINEXA reserves the right to amend this Framework to reflect regulatory updates, operational adjustments, or legal requirements. Continued engagement constitutes acceptance of the revised version.